RecruitingNCT06820450

Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis

STERONLINE: Steroidome and Exposome of Endometriosis Single-center Case-control Study


Sponsor

Nantes University Hospital

Enrollment

135 participants

Start Date

Jul 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Endometriosis is a systemic, steroid-dependent, inflammatory disease characterized by the growth of endometrial-like tissue outside the uterus, affecting approximately 10 % of women of childbearing age. The etiology and pathophysiology of endometriosis is not completely understood to support effective treatment and prevention strategies. Despite the steroid dependency, little is known concerning the underlying metabolism of estrogen and other tightly related steroids. Moreover, shortening the long diagnostic delays is a major priority in endometriosis research.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood test, urine sample, and others for people with endometriosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood test

A blood test (2 x 5 ml dry tubes) will be taken to analyze steroid profiles

OTHERurine sample

a 20 ml urine sample will be taken to analyze steroid profiles

OTHERvaginal sample

to characterize the microbiota.


Locations(1)

CHU de Nantes

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06820450


Related Trials